The Baltimore Breathmobile program has demonstrated significant improvement in SFDs, with direct medical cost savings of the program outweighing the operational costs.
These data support the need to continue to sustain and expand Breathmobile programs for children at high risk for asthma exacerbations and to conduct a randomized clinical trial to estimate the cost-effectiveness of the Breathmobile.
2010-10-11
Eng.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Division of Pediatric Pulmonology/Allergy, University of Maryland School of Medicine, Baltimore, Maryland, USA. mbolling [at] peds.umaryland.edu
Ann Allergy Asthma Immunol. 2010 Oct;105(4):274-281
© Galenicom 1999-2013